Recruiting NA INTERVENTIONAL 2-arm NCT03788213

One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer (HYPORTAdjuvant)

HYPOfractionated Radiation Therapy Comparing a Standard Radiotherapy Schedule (Over Three Weeks) With a Novel One Week Schedule in Adjuvant Breast Cancer: An Open Label Randomised Controlled Study (HYPORT- Adjuvant)

Sponsor: Christian Medical College, Vellore, India

Conditions Breast Cancer Female

Interventions 1 week RT 3 week RT

Updated 9 times since 2019 Last updated: Oct 21, 2024 Started: Mar 26, 2019 Primary completion: Mar 26, 2029 Completion: Mar 26, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03788213, this NA trial focuses on Breast Cancer Female and remains actively recruiting participants. Sponsored by Christian Medical College, Vellore, India, it has been updated 9 times since 2019, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

9 versions recorded

Nov 2024 — Present [monthly]

Recruiting NA
Sep 2024 — Nov 2024 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jan 2024 — Jul 2024 [monthly]

Recruiting NA
Jan 2022 — Jan 2024 [monthly]

Recruiting NA

▶ Show 4 earlier versions

Jan 2021 — Jan 2022 [monthly]

Recruiting NA
Feb 2020 — Jan 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Feb 2019 — Feb 2020 [monthly]

Not Yet Recruiting NA
Jan 2019 — Feb 2019 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Christian Medical College, Vellore, India
Kasturba Medical College
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Tata Medical Center

Data source: Tata Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kolkata, India